J ANAL TOXICOL 润色咨询

JOURNAL OF ANALYTICAL TOXICOLOGY

出版年份：1977 年文章数：1814 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：16.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1092431, encodeId=3f971092431dc, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092432, encodeId=eda61092432e7, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569697, encodeId=f7c156969e9d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：小硕一枚，毒物分析方向，第一篇SCI，历经重重困难，终于被接收啦！ 一审：2个月多。要求大修。审稿人仔细认真，意见比较中肯，对后续修改帮助很大，没要补实验。 大修返回后，1.5个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Thu Apr 18 00:00:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569250, encodeId=b317569250f4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：第一篇SCI，投稿JAT，过程很煎熬，不过accept之后超级开心。 <br> 小硕一枚，做体内毒物分析。一审周期：2个月多一点，最后给了大修，没要求补实验。审稿人很认真，提出的问题很专业，对我后期修改帮助很大，真心感谢。大修后，1个半月接收。 <br> 时间列表： <br> 2018.11.03——submit； <br> 2019.01.12—— major revision； <br> 2019.02.21——revision submit； <br> 2019.04.08——accept。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Mon Apr 08 14:39:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540121, encodeId=9661540121b3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498881, encodeId=a25c49888189, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：这个杂志挺厚道，审稿速度快，有一定新意跟毒理，毒性代谢产物相关容易中，偏重于临床相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 16:30:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819098, encodeId=f24b819098e4, content=这个杂志如何啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Thu Apr 19 00:43:00 CST 2012, time=2012-04-19, status=1, ipAttribution=)]
    2021-12-29 衣谷

    RUNINGTITLE是必须的么？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1092431, encodeId=3f971092431dc, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092432, encodeId=eda61092432e7, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569697, encodeId=f7c156969e9d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：小硕一枚，毒物分析方向，第一篇SCI，历经重重困难，终于被接收啦！ 一审：2个月多。要求大修。审稿人仔细认真，意见比较中肯，对后续修改帮助很大，没要补实验。 大修返回后，1.5个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Thu Apr 18 00:00:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569250, encodeId=b317569250f4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：第一篇SCI，投稿JAT，过程很煎熬，不过accept之后超级开心。 <br> 小硕一枚，做体内毒物分析。一审周期：2个月多一点，最后给了大修，没要求补实验。审稿人很认真，提出的问题很专业，对我后期修改帮助很大，真心感谢。大修后，1个半月接收。 <br> 时间列表： <br> 2018.11.03——submit； <br> 2019.01.12—— major revision； <br> 2019.02.21——revision submit； <br> 2019.04.08——accept。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Mon Apr 08 14:39:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540121, encodeId=9661540121b3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498881, encodeId=a25c49888189, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：这个杂志挺厚道，审稿速度快，有一定新意跟毒理，毒性代谢产物相关容易中，偏重于临床相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 16:30:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819098, encodeId=f24b819098e4, content=这个杂志如何啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Thu Apr 19 00:43:00 CST 2012, time=2012-04-19, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    RUNNINGTITLE和TITLE的区别？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1092431, encodeId=3f971092431dc, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092432, encodeId=eda61092432e7, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569697, encodeId=f7c156969e9d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：小硕一枚，毒物分析方向，第一篇SCI，历经重重困难，终于被接收啦！ 一审：2个月多。要求大修。审稿人仔细认真，意见比较中肯，对后续修改帮助很大，没要补实验。 大修返回后，1.5个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Thu Apr 18 00:00:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569250, encodeId=b317569250f4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：第一篇SCI，投稿JAT，过程很煎熬，不过accept之后超级开心。 <br> 小硕一枚，做体内毒物分析。一审周期：2个月多一点，最后给了大修，没要求补实验。审稿人很认真，提出的问题很专业，对我后期修改帮助很大，真心感谢。大修后，1个半月接收。 <br> 时间列表： <br> 2018.11.03——submit； <br> 2019.01.12—— major revision； <br> 2019.02.21——revision submit； <br> 2019.04.08——accept。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Mon Apr 08 14:39:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540121, encodeId=9661540121b3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498881, encodeId=a25c49888189, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：这个杂志挺厚道，审稿速度快，有一定新意跟毒理，毒性代谢产物相关容易中，偏重于临床相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 16:30:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819098, encodeId=f24b819098e4, content=这个杂志如何啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Thu Apr 19 00:43:00 CST 2012, time=2012-04-19, status=1, ipAttribution=)]
    2019-04-18 二氯卡宾

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：小硕一枚，毒物分析方向，第一篇SCI，历经重重困难，终于被接收啦！ 一审：2个月多。要求大修。审稿人仔细认真，意见比较中肯，对后续修改帮助很大，没要补实验。 大修返回后，1.5个月接受。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1092431, encodeId=3f971092431dc, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092432, encodeId=eda61092432e7, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569697, encodeId=f7c156969e9d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：小硕一枚，毒物分析方向，第一篇SCI，历经重重困难，终于被接收啦！ 一审：2个月多。要求大修。审稿人仔细认真，意见比较中肯，对后续修改帮助很大，没要补实验。 大修返回后，1.5个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Thu Apr 18 00:00:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569250, encodeId=b317569250f4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：第一篇SCI，投稿JAT，过程很煎熬，不过accept之后超级开心。 <br> 小硕一枚，做体内毒物分析。一审周期：2个月多一点，最后给了大修，没要求补实验。审稿人很认真，提出的问题很专业，对我后期修改帮助很大，真心感谢。大修后，1个半月接收。 <br> 时间列表： <br> 2018.11.03——submit； <br> 2019.01.12—— major revision； <br> 2019.02.21——revision submit； <br> 2019.04.08——accept。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Mon Apr 08 14:39:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540121, encodeId=9661540121b3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498881, encodeId=a25c49888189, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：这个杂志挺厚道，审稿速度快，有一定新意跟毒理，毒性代谢产物相关容易中，偏重于临床相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 16:30:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819098, encodeId=f24b819098e4, content=这个杂志如何啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Thu Apr 19 00:43:00 CST 2012, time=2012-04-19, status=1, ipAttribution=)]
    2019-04-08 二氯卡宾

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：第一篇SCI，投稿JAT，过程很煎熬，不过accept之后超级开心。
    小硕一枚，做体内毒物分析。一审周期：2个月多一点，最后给了大修，没要求补实验。审稿人很认真，提出的问题很专业，对我后期修改帮助很大，真心感谢。大修后，1个半月接收。
    时间列表：
    2018.11.03——submit；
    2019.01.12—— major revision；
    2019.02.21——revision submit；
    2019.04.08——accept。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1092431, encodeId=3f971092431dc, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092432, encodeId=eda61092432e7, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569697, encodeId=f7c156969e9d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：小硕一枚，毒物分析方向，第一篇SCI，历经重重困难，终于被接收啦！ 一审：2个月多。要求大修。审稿人仔细认真，意见比较中肯，对后续修改帮助很大，没要补实验。 大修返回后，1.5个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Thu Apr 18 00:00:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569250, encodeId=b317569250f4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：第一篇SCI，投稿JAT，过程很煎熬，不过accept之后超级开心。 <br> 小硕一枚，做体内毒物分析。一审周期：2个月多一点，最后给了大修，没要求补实验。审稿人很认真，提出的问题很专业，对我后期修改帮助很大，真心感谢。大修后，1个半月接收。 <br> 时间列表： <br> 2018.11.03——submit； <br> 2019.01.12—— major revision； <br> 2019.02.21——revision submit； <br> 2019.04.08——accept。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Mon Apr 08 14:39:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540121, encodeId=9661540121b3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498881, encodeId=a25c49888189, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：这个杂志挺厚道，审稿速度快，有一定新意跟毒理，毒性代谢产物相关容易中，偏重于临床相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 16:30:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819098, encodeId=f24b819098e4, content=这个杂志如何啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Thu Apr 19 00:43:00 CST 2012, time=2012-04-19, status=1, ipAttribution=)]
    2017-07-18 yang_liping1

    虽然今年没有什么大变化，以后再看看

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1092431, encodeId=3f971092431dc, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092432, encodeId=eda61092432e7, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569697, encodeId=f7c156969e9d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：小硕一枚，毒物分析方向，第一篇SCI，历经重重困难，终于被接收啦！ 一审：2个月多。要求大修。审稿人仔细认真，意见比较中肯，对后续修改帮助很大，没要补实验。 大修返回后，1.5个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Thu Apr 18 00:00:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569250, encodeId=b317569250f4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：第一篇SCI，投稿JAT，过程很煎熬，不过accept之后超级开心。 <br> 小硕一枚，做体内毒物分析。一审周期：2个月多一点，最后给了大修，没要求补实验。审稿人很认真，提出的问题很专业，对我后期修改帮助很大，真心感谢。大修后，1个半月接收。 <br> 时间列表： <br> 2018.11.03——submit； <br> 2019.01.12—— major revision； <br> 2019.02.21——revision submit； <br> 2019.04.08——accept。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Mon Apr 08 14:39:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540121, encodeId=9661540121b3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498881, encodeId=a25c49888189, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：这个杂志挺厚道，审稿速度快，有一定新意跟毒理，毒性代谢产物相关容易中，偏重于临床相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 16:30:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819098, encodeId=f24b819098e4, content=这个杂志如何啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Thu Apr 19 00:43:00 CST 2012, time=2012-04-19, status=1, ipAttribution=)]
    2013-09-09 匿名用户

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享：这个杂志挺厚道，审稿速度快，有一定新意跟毒理，毒性代谢产物相关容易中，偏重于临床相关

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1092431, encodeId=3f971092431dc, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092432, encodeId=eda61092432e7, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569697, encodeId=f7c156969e9d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：小硕一枚，毒物分析方向，第一篇SCI，历经重重困难，终于被接收啦！ 一审：2个月多。要求大修。审稿人仔细认真，意见比较中肯，对后续修改帮助很大，没要补实验。 大修返回后，1.5个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Thu Apr 18 00:00:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569250, encodeId=b317569250f4, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：第一篇SCI，投稿JAT，过程很煎熬，不过accept之后超级开心。 <br> 小硕一枚，做体内毒物分析。一审周期：2个月多一点，最后给了大修，没要求补实验。审稿人很认真，提出的问题很专业，对我后期修改帮助很大，真心感谢。大修后，1个半月接收。 <br> 时间列表： <br> 2018.11.03——submit； <br> 2019.01.12—— major revision； <br> 2019.02.21——revision submit； <br> 2019.04.08——accept。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/24/5df21ac135d837ba23b9681341de6726.jpg, createdBy=99602056210, createdName=二氯卡宾, createdTime=Mon Apr 08 14:39:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540121, encodeId=9661540121b3, content=虽然今年没有什么大变化，以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498881, encodeId=a25c49888189, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：这个杂志挺厚道，审稿速度快，有一定新意跟毒理，毒性代谢产物相关容易中，偏重于临床相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 16:30:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819098, encodeId=f24b819098e4, content=这个杂志如何啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Thu Apr 19 00:43:00 CST 2012, time=2012-04-19, status=1, ipAttribution=)]
    2012-04-19 ms9686134410729756

    这个杂志如何啊？

    0

共10条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分